EverSource Wealth Advisors’s Gossamer Bio GOSS Stock Holding History

EverSource Wealth Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.19K	Buy	167 +93	+126%	+$2.08K	﹤0.01%	3689
2026 Q1	$1.96K	Buy	74 +66	+825%	+$8.3K	﹤0.01%	3649
2025 Q4	$2.03K	Buy	8 +2	+33%	+$457	﹤0.01%	3493
2025 Q3	$1.23K	Buy	+6	New	+$1.06K	﹤0.01%	3694

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

EverSource Wealth Advisors's GOSS Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Gossamer Bio (GOSS) stake by 126% in Q2 2026, buying an estimated $2.08K and bringing the position to 167 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

EverSource Wealth Advisors first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

EverSource Wealth Advisors held 167 shares of Gossamer Bio worth $2.19K as of Q2 2026.
EverSource Wealth Advisors bought 93 Gossamer Bio shares in Q2 2026, an estimated $2.08K.
Gossamer Bio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3689 holding.
EverSource Wealth Advisors first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.